Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Roberts

Showing results (231-240 of 239) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 239 results.
Cancer Research|September 1, 1988
Phase I clinical and pharmacokinetic study of trimetrexate using a daily x5 scheduleJ A Stewart, J J McCormack, W Tong, et al.
Genomics|June 10, 1995
Three members of the nitric oxide synthase II gene family (NOS2A, NOS2B, and NOS2C) colocalize to human chromosome 17K D Bloch, J R Wolfram, D M Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|March 10, 2001
A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamicsB D Kavanagh, S R Khandelwal, R K Schmidt-Ullrich, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeksJ D Roberts, S Shibata, D V Spicer, et al.
The New England Journal of Medicine|February 27, 1997
Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study GroupJ D Roberts, J R Fineman, F C Morin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034H L McLeod, J Cassidy, R H Powrie, et al.
The Pharmacogenomics Journal|April 8, 2015
A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI studyD Y F So, G A Wells, R McPherson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumorsS J Wong, T Karrison, D N Hayes, et al.
Science (New York, N.Y.)|May 8, 2010
Climate change and the integrity of scienceP H Gleick, R M Adams, R M Amasino, et al.
Pageof 24

Showing results (231-240 of 239) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 239 results.
Cancer Research|September 1, 1988
Phase I clinical and pharmacokinetic study of trimetrexate using a daily x5 scheduleJ A Stewart, J J McCormack, W Tong, et al.
Genomics|June 10, 1995
Three members of the nitric oxide synthase II gene family (NOS2A, NOS2B, and NOS2C) colocalize to human chromosome 17K D Bloch, J R Wolfram, D M Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|March 10, 2001
A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamicsB D Kavanagh, S R Khandelwal, R K Schmidt-Ullrich, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeksJ D Roberts, S Shibata, D V Spicer, et al.
The New England Journal of Medicine|February 27, 1997
Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study GroupJ D Roberts, J R Fineman, F C Morin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034H L McLeod, J Cassidy, R H Powrie, et al.
The Pharmacogenomics Journal|April 8, 2015
A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI studyD Y F So, G A Wells, R McPherson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumorsS J Wong, T Karrison, D N Hayes, et al.
Science (New York, N.Y.)|May 8, 2010
Climate change and the integrity of scienceP H Gleick, R M Adams, R M Amasino, et al.
Pageof 24